$BHVN

Biohaven Ltd

$BHVN

Biohaven Ltd

Past 12mo:8mentions1voices

All voices3 calls since Oct 2025show all

Loading price chart…

Recent calls

3 calls

@adamfeuersteinNov 6, 2025 · 2:27 PM

This week's Biotech Scorecard newsletter: The FDA is a mess, but don't blame it for everything I write about $QURE and $BHVN Re: Uniqure and its gene therapy for Huntington's disease, the dissonance between the FDA's words and actions can be confusing. Approving AMT-130 seems like a no-brainer win for the FDA and the policy initiatives pushed by its leadership. The reversal certainly has Prasad's conservative data-stickler fingerprints all over it, BUT... You have to consider the possibility that there is a significant issue with the AMT-130 data, the composition of the external control group, or both, that Uniqure hasn’t disclosed. Slingshot Insights hosted a call Tuesday with an HD physician who was critical of the AMT-130 data, saying the therapy was "far from ready for approval."

Open on X

@adamfeuersteinNov 5, 2025 · 1:36 AM

$BHVN rejection https://t.co/h0TFXkDyk1

Open on X

@adamfeuersteinOct 9, 2025 · 5:31 PM

The limits of FDA flexibility are tested as a controversial Biohaven $BHVN drug decision nears https://t.co/MaqnNoshrV

Open on X

Frequently asked

Who mentions $BHVN most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $BHVN most — 8 mentions in the past 12 months.

When was $BHVN first mentioned on Surfaced?

The earliest tracked mention of $BHVN in the Surfaced archive was on Sep 25, 2025.

How many voices track $BHVN?

1 FinTwit voice has mentioned $BHVN 8 times in the past 12 months.

What kind of voices mention $BHVN most?

$BHVN is mentioned most by Biotech voices on Surfaced.